2021
DOI: 10.9734/jpri/2021/v33i28b31552
|View full text |Cite
|
Sign up to set email alerts
|

Endoscopic Pilonidal Sinus Treatment (EPSIT): Is a New Minimally Invasive Treatment in Pilonidal Sinus

Abstract: Objective: To determine the outcome of endoscopic pilonidal sinus treatment (EPSIT): Is a new minimally invasive treatment in pilonidal sinus. Study Design: This is a observational study. Setting: Study carried out at General Surgery department, Liaquat University of Medical and Health Sciences Jamshoro, form March 2020 to Feb 2021. Materials and Methods:  Patients aged between 20-40 years, both gender having sinus in the cleft of the buttocks on clinical examination with associated symptoms … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…Traditional procedures to achieve complete excision of the pilonidal sinus and secondary tracts lead to large wounds/scars, causing significant pain, immobility, burdensome wound care, and longer period off work. 11,14 EPSiT, like other minimally invasive techniques, has an advantage over conventional techniques; it can be performed as a day-care procedure. EPSiT is an adoption from VAAFT and is performed with the same instruments.…”
Section: Discussionmentioning
confidence: 99%
“…Traditional procedures to achieve complete excision of the pilonidal sinus and secondary tracts lead to large wounds/scars, causing significant pain, immobility, burdensome wound care, and longer period off work. 11,14 EPSiT, like other minimally invasive techniques, has an advantage over conventional techniques; it can be performed as a day-care procedure. EPSiT is an adoption from VAAFT and is performed with the same instruments.…”
Section: Discussionmentioning
confidence: 99%